{"id":149942,"date":"2025-09-17T14:42:09","date_gmt":"2025-09-17T14:42:09","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/149942\/"},"modified":"2025-09-17T14:42:09","modified_gmt":"2025-09-17T14:42:09","slug":"fda-cracks-down-on-prescription-drug-ads-but-lacks-staff","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/149942\/","title":{"rendered":"FDA cracks down on prescription drug ads but lacks staff"},"content":{"rendered":"

WASHINGTON \u2013\u00a0In an unprecedented move, federal regulators published about 100 warning letters sent to pharmaceutical companies and health care providers, ordering them to stop or alter ads or other promotions the government considered misleading.<\/p>\n

The letters went to major drugmakers like Novartis and Eli Lilly, and to telehealth firms like Hims & Hers, shortly after the Trump administration announced the advertising crackdown<\/a>. But experts questioned whether the Food and Drug Administration has the resources to prosecute this aggressive campaign after laying off many of the experienced staff who would lead the effort.<\/p>\n

\u201cWhat happens when those 100 responses come in, and how is FDA going to prioritize its review of those?\u201d said Joshua Oyster, a partner at Ropes & Gray. \u201cHow is the FDA going to prioritize follow-up actions, if any, in response to those responses?\u201d<\/p>\n

STAT+ Exclusive Story<\/p>\n

Already have an account? Log in<\/a><\/p>\n

\t\t\t\"STAT+\"\/<\/p>\n

\t\t\t\t\t
\n\t\t\t\t\t\t\"STAT+\"\/
\n\t\t\t\t\t<\/a><\/p>\n

\t\t\t\tThis article is exclusive to STAT+ subscribers
\n\t\t\t\tUnlock this article \u2014 plus daily intelligence on Capitol Hill and the life sciences industry \u2014 by subscribing to STAT+.<\/p>\n

Already have an account? Log in<\/a><\/p>\n

\t\t\t\t\t\tIndividual plans<\/p>\n

\t\t\t\t\t\tGroup plans<\/p>\n

\t\t\t\tView All Plans<\/a><\/p>\n

\n\t\t\t\t\t\tTo read the rest of this story subscribe to STAT+.\t\t\t\t\t<\/p>\n

\t\t\t\t\tSubscribe<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"WASHINGTON \u2013\u00a0In an unprecedented move, federal regulators published about 100 warning letters sent to pharmaceutical companies and health…\n","protected":false},"author":2,"featured_media":149943,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[64,63,4335,2156,137,490,4334,10839,1837,1677],"class_list":{"0":"post-149942","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-au","9":"tag-australia","10":"tag-biotechnology","11":"tag-fda","12":"tag-health","13":"tag-medication","14":"tag-pharmaceuticals","15":"tag-policy","16":"tag-rfk-jr","17":"tag-stat"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/149942","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=149942"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/149942\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/149943"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=149942"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=149942"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=149942"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}